Furthermore, our observations indicate a reduction of PD-1+ CD4 Tconv cells in VAT of obese patients with dysglycemic and an augmentation in the liver of individuals with NASH and type 2 diabetes. This evidence concerns the gene CD4 and type 2 diabetes mellitus.